Alpha Synuclein Constructs for Neurodegenerative Disease Research
StressMarq has developed unique alpha synuclein constructs to provide invaluable support to researchers engaged in disease model development and the
Read moreStressMarq has developed unique alpha synuclein constructs to provide invaluable support to researchers engaged in disease model development and the
Read moreStressMarq is a pioneer in the development of tau proteins that facilitate the investigation of tau aggregation, a key characteristic
Read moreParkinson’s Disease is characterized by the aggregation of alpha-synuclein, a key pathological feature. In this informative video, the mechanism underlying
Read moreTau is a key protein implicated in neurodegenerative diseases, such as Alzheimer’s and dementia. Tau Pre-formed Fibrils (PFFs) for Modelling
Read moreSonification: What, Why, How and Best Practices A StressMarq Biosciences .pdf White Paper Neurodegenerative Disease Research As populations age, the
Read moreMcMaster University and the Massachusetts Institute of Technology researchers using artificial intelligence (AI) have discovered a new type of antibiotic
Read moreWith the 3-D Life Slow Gelling hydrogel kits, the set-up of 3D cell culture is easy. Growing cells in a
Read moreChicago Headquartered Tempus, pioneering AI-enabled precision medicine, has entered a third strategic collaboration with pharma giant Pfizer, aiming to gather
Read moreTransCode Therapeutics and BRAIN Biotech have entered a joint research and development agreement (JDA) with the objective to co-develop a
Read moreStemBioSys, Inc. (StemBioSys) announced on Monday, the launch of NeuroMatrix™, an astrocyte-derived extracellular matrix that is developed to enable the
Read more